scholarly journals NMR-based metabolomic profile of cold stun syndrome in loggerhead Caretta caretta, green Chelonia mydas and Kemp's ridley Lepidochelys kempii sea turtles in North Carolina, USA

2020 ◽  
Vol 2020 (1) ◽  
Author(s):  
Jennifer N. Niemuth ◽  
Craig A. Harms ◽  
Jeffrey M. Macdonald ◽  
Michael K. Stoskopf
Chemosphere ◽  
2010 ◽  
Vol 78 (6) ◽  
pp. 731-741 ◽  
Author(s):  
Robert F. Swarthout ◽  
Jennifer M. Keller ◽  
Margie Peden-Adams ◽  
Andre M. Landry ◽  
Patricia A. Fair ◽  
...  

2019 ◽  
Vol 22 (6) ◽  
pp. 910-915 ◽  
Author(s):  
Melissa J. Lively ◽  
Hans D. Westermeyer ◽  
Craig A. Harms ◽  
Emily F. Christiansen

Animals ◽  
2020 ◽  
Vol 10 (11) ◽  
pp. 1964 ◽  
Author(s):  
Annie Page-Karjian ◽  
Maria E. Serrano ◽  
Jeffrey Cartzendafner ◽  
Ashley Morgan ◽  
Branson W. Ritchie ◽  
...  

Fibropapillomatosis is associated with chelonid alphaherpesvirus 5 (ChHV5) and tumor formation in sea turtles. We collected blood samples from 113 green (Chelonia mydas) and 112 loggerhead (Caretta caretta) turtles without fibropapillomatosis, including 46 free-ranging turtles (20 green turtles, 26 loggerheads), captured in Core Sound, North Carolina, and 179 turtles (93 green turtles, 86 loggerheads) in rehabilitative care in North Carolina. Blood samples were analyzed for ChHV5 DNA using quantitative polymerase chain reaction (qPCR), and for antibodies to ChHV5 peptides using an enzyme-linked immunosorbent assay (ELISA). None of the samples from foraging turtles tested positive for ChHV5 by qPCR; ELISA was not used for foraging turtles. Samples from 18/179 (10.1%) rehabilitating turtles tested positive for ChHV5 using qPCR, and 32/56 (57.1%) rehabilitating turtles tested positive for antibodies to ChHV5 using ELISA. Five turtles that tested positive by qPCR or ELISA at admission converted to being undetectable during rehabilitation, and five that initially tested negative converted to being positive. Both sea turtle species were significantly more likely to test positive for ChHV5 using ELISA than with qPCR (p < 0.001). There was no difference in the proportions of green turtles versus loggerheads that tested positive for ChHV5 using qPCR, but loggerheads were significantly more likely than green turtles to test positive for ChHV5 using ELISA. This finding suggests that loggerheads infected with ChHV5 at some point in their life may be more able than green turtles to mount an effective immune response against recrudescent infection, pointing to species-specific genetic differences in the two species’ immune response to ChHV5 infection. This is the first study to analyze antibodies to ChHV5 in loggerhead turtles and represents the most complete dataset on ChHV5 DNA detection in sea turtles encountered in the more northern latitudes of their western Atlantic habitat.


2020 ◽  
Vol 2 (1) ◽  
Author(s):  
K E Hunt ◽  
C Merigo ◽  
E A Burgess ◽  
C Loren Buck ◽  
D Davis ◽  
...  

Synopsis Many juvenile Kemp’s ridley (Lepidochelys kempii) and loggerhead (Caretta caretta) turtles strand during fall on the beaches of Cape Cod (MA, USA), with total stranding numbers sometimes exceeding 300 turtles per year. Once rehabilitated, turtles must be released at beaches with appropriate water temperatures, often requiring transportation to southeastern coastal states of the USA. These transportation events (transports) may approach or exceed 24 h in duration. Kemp’s ridley turtles are known to exhibit an adrenal stress response during such transports, but the effect of transport duration has been unclear, and no other sea turtle species has been investigated. To assess whether transport duration and/or species affects physiological reactions to transport, we studied pre- and post-transport physiological measures in Kemp’s ridley and loggerhead turtles transported by ground for &lt;6, ∼12, ∼18, or ∼24 h, comparing with matched “control events” in which turtles were studied without transport. Blood samples were analyzed for four stress-associated measures (corticosterone, glucose, total white blood cell [WBC] count, and heterophil/lymphocyte ratio [H/L]) and nine measures of clinical status (pH, pO2, pCO2, HCO3, sodium, potassium, ionized calcium, lactate, and hematocrit). In both species, stress-associated measures elevated significantly during transport, while handling without transport had no significant effects. Loggerheads exhibited a greater stress response than Kemp’s ridleys across all transport durations. These results indicate that sea turtles do react physiologically to ground transport; therefore, minimizing transport time and streamlining transport logistics (where feasible) may help ensure release of rehabilitated turtles to sea in the best possible condition. Nonetheless, both species remained in good clinical condition even after 24 h transport, indicating that current transport protocols are generally safe for sea turtles from a clinical perspective.


2015 ◽  
Vol 276 (8) ◽  
pp. 929-940 ◽  
Author(s):  
Michael Salmon ◽  
Benjamin Higgins ◽  
Joshua Stewart ◽  
Jeanette Wyneken

Animals ◽  
2021 ◽  
Vol 11 (12) ◽  
pp. 3522
Author(s):  
Terry M. Norton ◽  
Tonya Clauss ◽  
Rachel Overmeyer ◽  
Stephanie Stowell ◽  
Michelle Kaylor ◽  
...  

The objective of this study was to determine the pharmacokinetics and safety of multiple injections of meloxicam (MLX) administered subcutaneously (SQ) in Kemp’s ridley (Lepidochelys kempii) and green (Chelonia mydas) sea turtles. Based on results from a previously published single-injection study, a multiple-injection regimen was derived for the Kemp’s ridleys, which consisted of administering MLX at a dose of 1 mg/kg SQ every 12 h for 5 days, and for green turtles at a dose of 1 mg/kg SQ every 48 h for three treatments. Six turtles of each species were used for the study, and blood samples were taken at multiple time intervals. The terminal half-life after the last dose for the Kemp’s ridley sea turtles was calculated at 7.18 h, and for the green sea turtles at 23.71 h. Throughout the multiple injections, MLX concentrations remained above 0.57 µg/mL, a concentration targeted in humans for the analgesic and anti-inflammatory effects. No negative side effects or changes to blood parameters evaluated were observed during the study in either species. The results of this study suggest MLX should be administered SQ to Kemp’s ridley sea turtles at a dosage of 1 mg/kg every 12 h and in green sea turtles at a dose of 1 mg/kg every 48 h. The novelty of this work is that it is a multiple-injection study. Multiple injections were administered and produced concentrations that were considered therapeutic in humans, and the turtles did not have any adverse side effects. Furthermore, there were large differences in the pharmacokinetic values between green and Kemp’s ridley sea turtles.


Sign in / Sign up

Export Citation Format

Share Document